Consensus Waters Corporation

Stocks

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 01:30:02 13/06/2026 am IST			5-day change	1st Jan Change
355.53 ^USD	-1.17%		-2.69%	-6.40%

11/06	Piper Sandler Initiates Waters at Neutral With $400 Price Target	MT
08/06	Waters Corporation Launches BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns	CI

Evolution of the Average Target: Waters Corporation

Evolution of the Target Price: Waters Corporation

Changes in Analyst Recommendations: Waters Corporation

2b0a1dc272.KbIYfu5JnRL8SVchsxgplzGRx_y39L2mJjW3kr6YLD0.ed1rSK8t5VOVezxy0F1OwXnUl5aBhs7tS3vk0fjic19a0Xkxqw3PdIR-PA~dcbac3970643c5b4471d4b6ce1f93b21

Analysts' recommendations: Waters Corporation

11/06	Piper Sandler Initiates Waters at Neutral With $400 Price Target	MT
03/06	HSBC Adjusts Price Target on Waters to $435 From $415, Maintains Buy Rating	MT
02/06	BofA Securities Adjusts Price Target on Waters to $400 From $370	MT
14/05	Wells Fargo Adjusts Price Target on Waters to $370 From $355, Maintains Equalweight Rating	MT
06/05	Deutsche Bank Adjusts Price Target on Waters to $350 From $330	MT
06/05	UBS Adjusts Price Target on Waters to $375 From $330, Maintains Neutral Rating	MT
06/05	Analyst recommendations: AMD, KKR, PayPal Holdings, Arista Networks, and TransDigm Group.
06/05	TD Cowen Adjusts Price Target on Waters to $385 From $345	MT
16/04	Leerink Partners Adjusts Price Target on Waters to $420 From $430, Maintains Outperform Rating	MT
13/04	UBS Adjusts Price Target on Waters to $330 From $370, Maintains Neutral Rating	MT
13/04	TD Cowen Adjusts Price Target on Waters to $345 From $373, Maintains Hold Rating	MT
08/04	Wolfe Research Adjusts Price Target on Waters to $400 From $480, Maintains Outperform Rating	MT
06/04	Evercore ISI Upgrades Waters to Outperform From In Line, Adjusts Price Target to $350 From $360	MT
27/03	HSBC Adjusts Waters Price Target to $415 From $460, Maintains Buy Rating	MT
25/03	Deutsche Bank Adjusts Waters Price Target to $330 From $370, Maintains Hold Rating	MT
23/02	Morgan Stanley Cuts Price Target on Waters to $350 From $423, Keeps Equalweight Rating	MT
18/02	Rothschild & Co Redburn Adjusts Price Target on Waters to $435 From $460, Maintains Buy Rating	MT
11/02	Wells Fargo Adjusts Waters Price Target to $355 From $415, Maintains Equal Weight Rating	MT
11/02	Wells Fargo Lowers Price Target on Waters to $355 From $415, Maintains Equalweight Rating	MT
10/02	UBS Adjusts Waters Price Target to $370 From $395, Maintains Neutral Rating	MT
10/02	TD Cowen Adjusts Waters PT to $373 From $400, Maintains Hold Rating	MT
10/02	JPMorgan Adjusts Price Target on Waters to $330 From $360, Maintains Neutral Rating	MT
10/02	Leerink Partners Adjusts Price Target on Waters to $430 From $425, Maintains Outperform Rating	MT
10/02	Baird Adjusts Price Target on Waters to $362 From $398, Maintains Outperform Rating	MT
27/01	HSBC Initiates Waters at Buy With $460 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	WATERS CORPORATION					+12.58%
	THERMO FISHER SCIENTIFIC, INC.					+27.67%
	INTUITIVE SURGICAL, INC.					+37.47%
	DANAHER CORPORATION					+34.56%
	BOSTON SCIENTIFIC CORPORATION					+64.36%
	EDWARDS LIFESCIENCES CORPORATION					+13.88%
	SIEMENS HEALTHINEERS AG					+43.16%
	AGILENT TECHNOLOGIES, INC.					+23.5%
	GE HEALTHCARE TECHNOLOGIES INC.					+22.31%
	RESMED, INC.					+38.93%
	Average					+31.84%
	Weighted average by Cap.					+33.56%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

355.53USD

Average target price

400.27USD

Spread / Average Target

+12.58%

High Price Target

460.00USD

Spread / Highest target

+29.38%

Low Price Target

345.00USD

Spread / Lowest Target

-2.96%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Piper Sandler
HSBC
BofA Securities
Wells Fargo Securities
Deutsche Bank Securities
UBS
TD Cowen
Leerink Partners
Wolfe Research
Evercore ISI
Morgan Stanley
Rothschild & Co Redburn
JPMorgan Chase
Baird
Guggenheim
William Blair & Co.
Jefferies & Co.
Stifel Nicolaus
Bernstein
Scotiabank
Barclays
Citigroup
Nephron Research
KeyBanc Capital Markets
Goldman Sachs
Morningstar
SVB Securities LLC
Credit Suisse
SVB Leerink